LEIGHANNA OUNANIAN: Open Payments
NPI 1699253633 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,625 in 77 payments from 29 companies in 2025. Trend: 2023 $1,273 · 2024 $3,314 · 2025 $1,625
Food & beverage: $1,625
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $208 |
| PFIZER INC. | 8 | $173 |
| Daiichi Sankyo Inc. | 8 | $163 |
| Merck Sharp & Dohme LLC | 7 | $122 |
| Janssen Biotech, Inc. | 6 | $120 |
| Incyte Corporation | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| BeOne Medicines USA, Inc. | 2 | $55 |
| JAZZ PHARMACEUTICALS INC. | 2 | $49 |
Products named: KEYTRUDA, Enhertu, KISQALI, RYBREVANT, Fabhalta, Epkinly, IBRANCE, INLYTA.
Industry payments across TX — which companies pay providers there.
